We are live on ! Find out more
FAF

Fjarde Ap-fonden Portfolio holdings

AUM $20.9B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+1.07%
1 Year Est. Return
+36.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.67B
AUM Growth
-$362M
Cap. Flow
-$380M
Cap. Flow %
-8.14%
Top 10 Hldgs %
17.49%
Holding
616
New
5
Increased
10
Reduced
556
Closed
6

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$17.9M
2
MSFT icon
Microsoft
MSFT
+$9.54M
3
XOM icon
ExxonMobil
XOM
+$9.52M
4
FRX
FOREST LABORATORIES INC
FRX
+$7.55M
5
LBTYK icon
Liberty Global Class C
LBTYK
+$7.42M

Sector Composition

Rank Sector Weight
1 Technology 15%
2 Financials 14.79%
3 Healthcare 14.69%
4 Energy 9.6%
5 Industrials 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAL icon
76
Halliburton
HAL
$26.4B
$13.8M 0.3%
214,108
-19,042
-8% -$1.31M
EOG icon
77
EOG Resources
EOG
$77.5B
$13.8M 0.29%
138,912
-10,740
-7% -$1.17M
LOW icon
78
Lowe's Companies
LOW
$118B
$13.7M 0.29%
259,654
-23,089
-8% -$1.17M
WBA
79
DELISTED
Walgreens Boots Alliance
WBA
$13.7M 0.29%
231,499
-17,261
-7% -$1.13M
F icon
80
Ford
F
$59.3B
$13.6M 0.29%
921,039
-72,964
-7% -$1.25M
AGN
81
DELISTED
Allergan Inc
AGN
$13.5M 0.29%
75,792
-6,161
-8% -$1.02M
DUK icon
82
Duke Energy
DUK
$98.4B
$13.4M 0.29%
179,459
-13,394
-7% -$977K
TXN icon
83
Texas Instruments
TXN
$255B
$13.1M 0.28%
274,656
-23,406
-8% -$1.12M
MS icon
84
Morgan Stanley
MS
$330B
$13.1M 0.28%
378,811
-30,036
-7% -$1M
ACN icon
85
Accenture
ACN
$99.9B
$13.1M 0.28%
160,831
-14,082
-8% -$1.13M
APC
86
DELISTED
Anadarko Petroleum
APC
$13M 0.28%
128,237
-9,840
-7% -$1.06M
SPG icon
87
Simon Property Group
SPG
$74.7B
$12.9M 0.28%
78,578
-7,383
-9% -$1.24M
LYB icon
88
LyondellBasell Industries
LYB
$19.5B
$12.6M 0.27%
115,653
-13,027
-10% -$1.41M
MET icon
89
MetLife
MET
$62.5B
$12.4M 0.27%
259,888
-21,436
-8% -$1.04M
COV
90
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$12.4M 0.27%
143,336
+19,340
+16% +$1.71M
TMO icon
91
Thermo Fisher Scientific
TMO
$214B
$12.3M 0.26%
100,876
-6,246
-6% -$759K
DHR icon
92
Danaher
DHR
$138B
$12.1M 0.26%
236,428
-16,953
-7% -$872K
COF icon
93
Capital One
COF
$129B
$11.8M 0.25%
145,135
-12,102
-8% -$990K
PSX icon
94
Phillips 66
PSX
$84.4B
$11.7M 0.25%
143,484
-17,610
-11% -$1.47M
PNC icon
95
PNC Financial Services
PNC
$99.2B
$11.6M 0.25%
135,801
-10,920
-7% -$929K
TFCFA
96
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$11.4M 0.24%
332,406
-39,694
-11% -$1.37M
FDX icon
97
FedEx
FDX
$73B
$11.4M 0.24%
70,748
-10,751
-13% -$1.63M
MCK icon
98
McKesson
MCK
$101B
$11.4M 0.24%
58,670
-4,361
-7% -$839K
BLK icon
99
Blackrock
BLK
$170B
$11.2M 0.24%
34,125
-2,918
-8% -$939K
BNY
100
Bank of New York Mellon
BNY
$106B
$11.2M 0.24%
287,892
-20,738
-7% -$806K

Similar funds

Fjarde Ap-fonden's Q3 2014 Portfolio in Review

As of Q3 2014, Fjarde Ap-fonden held 616 positions worth $4.67B, down 7.2% from $5.03B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Fjarde Ap-fonden withdrew a net $380M in Q3 2014, closing 6 positions and reducing 556 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $7.55M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Fjarde Ap-fonden opened a new position in Liberty Media Series C worth $9.8M.

  • Fjarde Ap-fonden's largest Q3 2014 buy was Liberty Media Series C: 429,371 shares worth $9.8M.
  • Fjarde Ap-fonden added most to Allergan plc in Q3 2014, an estimated $8.06M increase.
  • Fjarde Ap-fonden's biggest Q3 2014 reduction was Apple, cutting an estimated $17.9M.
  • Fjarde Ap-fonden fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $7.55M.
  • Fjarde Ap-fonden's ten largest holdings make up 17% of its $4.67B portfolio in Q3 2014.
  • Fjarde Ap-fonden opened 5 new positions and closed 6 in Q3 2014.
  • Fjarde Ap-fonden's portfolio value fell 7.2% quarter-over-quarter to $4.67B.

Based on Fjarde Ap-fonden's 13F filing for Q3 2014, filed 6 Nov 2014.